A study for a 30 year old man who takes Stribild - from FDA reports

102 males aged 30 (±5) who take the same drug are studied. This is a personalized study for a 30 year old male patient who has Hiv. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Aug, 14, 2018

102 males aged 30 (±5) who take Stribild are studied.

Number of reports submitted per year:

Stribild for a 30-year old man.

Information of the patient in this study:

  • Age: 30
  • Gender: male
  • Conditions: Hiv
  • Drugs taken:
    • Stribild (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Oral disorder (mouth disease)
  2. Suicidal ideation
  3. Fever
  4. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  5. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
1 - 6 months:
  1. Feeling abnormal
  2. Memory loss
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Nephropathy toxic (damage to kidney due to toxins)
  5. Suicidal ideation
6 - 12 months:
  1. Viral load increased
  2. Drug resistance (reduction in effectiveness of a drug)
  3. Drug ineffective
  4. Blood creatinine increased
  5. Glomerular filtration rate decreased
1 - 2 years:
2 - 5 years:
  1. Hepatomegaly (abnormal enlargement of the liver)
  2. Splenomegaly (enlargement of spleen)
  3. Weight increased
  4. Hepatic enzyme increased
  5. High blood pressure
5 - 10 years:
10+ years:
not specified:
  1. Abnormal sleep-related event
  2. Ocular hyperaemia (an abnormally large amount of blood in eye)
  3. Eosinophilic pustular folliculitis (bacterial skin diseases)
  4. Numbness and tingling (unusual prickling sensations)
  5. Neuropathy peripheral (surface nerve damage)

Top conditions involved for these people *:

  1. Asthma : 4 people, 3.92%
  2. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 1.96%
  3. Bipolar Disorder (mood disorder): 2 people, 1.96%
  4. Infection : 1 person, 0.98%
  5. Asymptomatic Hiv Infection : 1 person, 0.98%

Top co-used drugs for these people *:

  1. Atripla (6 people, 5.88%)
  2. Prezista (2 people, 1.96%)
  3. Norvir (2 people, 1.96%)
  4. Tivicay (2 people, 1.96%)
  5. Symbicort (2 people, 1.96%)

* Some reports may have incomplete information.

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.